DiappyMed, founded in 2021 and based in France, is a pioneering company in the Health Care and Manufacturing industries. Their focus is on enhancing the lives of individuals with diabetes (Type 1 and 2) by integrating cutting-edge digital solutions.
With the slogan "Alléger le diabète avec des outils digitaux," DiappyMed offers two primary products: EkiYou Carbs, a mobile application for precise carbohydrate counting, and EkiYou, a digital therapy facilitating insulin dose recommendations tailored to meals, physical activity, and glycemia levels. Notably, EkiYou holds the CE Class IIb medical device certification.
These tools are developed in collaboration with a robust medical committee and a dedicated patient community, comprising 2000 users, ensuring clinical relevance and user-centric design. While DiappyMed has yet to benefit from external investments, its innovation and dedication to user-focused diabetes management position it as an appealing prospect for future investors seeking impact-driven healthcare solutions.